North Dakota med spa & injectable regulations
What’s changing for med spas and injectors in North Dakota — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in North Dakota. MedSpaRadar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa in North Dakota? Start with who may own one, the medical director rules, and who may inject in North Dakota →
Latest North Dakota changes
No North Dakota-specific changes have crossed our radar yet — we’re monitoring the North Dakota legislature daily. The North Dakota legislature has adjourned sine die (2026 1st Special Session). No further session is listed yet. The federal changes below apply to every North Dakota practice today.
Federal changes that apply in North Dakota
FDA and Federal Register actions are nationwide — they govern North Dakota practices too.
- MONITORFEDERALPrimary Source MonitoringSep 21, 2026
Primary Source Monitoring: Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
Caution urged due to recent conviction for selling misbranded drugs.
- MONITORFEDERALPrimary Source MonitoringSep 17, 2026
Primary Source Monitoring: Korea Filler Experts - 718706 - 11/03/2025
FDA warns koreafillerexperts.com over unapproved, misbranded injectable botulinum toxin.
- CRITICALFEDERALFDA Device RecallSep 16, 2026
FDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
FDA recalls DermaV Laser System; check for safety compliance.
- MONITORFEDERALPrimary Source MonitoringSep 16, 2026
Primary Source Monitoring: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
FDA updates compounding guidelines as GLP-1 supplies stabilize.
- MONITORFEDERALPrimary Source MonitoringSep 15, 2026
Primary Source Monitoring: Hefner v. Rock Valley Compounding Pharmacy, LLC (3:26-cv-01298) — District Court, S.D. Illinois
Legal case filed affecting compounding pharmacy standards.
- MONITORFEDERALPrimary Source MonitoringSep 9, 2026
Primary Source Monitoring: Human Drug Compounding Policies and Rules
FDA's compounding policy index adds a September 2026 neonatal nutrition guidance.
What we monitor in North Dakota
- North Dakota legislature — bills on injectables, GLP-1s & scope of practice
- North Dakota Attorney General — Enforcement and consumer-protection announcements, including actions against unlicensed practice.
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
North Dakota med spa questions, answered from statute
The same verified record, asked the way operators actually ask it — who may own one, who may inject, what the supervising physician has to do. 20 questions have a cited North Dakota answer today.
Browse the 20 North Dakota questions →North Dakota med-spa compliance rules
38 rules across 7 topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.
Physician supervision & delegation9 cited rules
The Medical Practice Act itself sets the terms on which a physician assistant may practice.
- All 9 cited rules: North Dakota medical director requirements →
- Does a med spa in North Dakota need a medical director? →
- Who may operate a cosmetic laser in North Dakota? →
- Can a medical assistant give injections in North Dakota? →
- Can a physician assistant inject or prescribe in North Dakota? →
- May an esthetician or laser technician perform microneedling in North Dakota? →
Good-faith examination6 cited rules
Section 43-17-44 opens by holding a licensee to the same standard of care and the same ethical standards whether the practice is traditional in-person medicine or telemedicine.
Ownership & corporate practice of medicine3 cited rules
The chapter read does not state a corporate-practice doctrine, but it does regulate the money directly, in the disciplinary grounds.
RN / NP scope for injectables2 cited rules
The Nurse Practices Act defines an advanced practice registered nurse as one licensed in the state within one of four roles — certified nurse practitioner, certified registered nurse anesthetist, certified nurse midwife or certified clinical nurse specialist — and functioning in a population focus the board approves.
Med-spa registration & licensing8 cited rules
The section that looks like a facility rule is repealed. 43-17-16 reads, in full, "License required. Repealed by S.L. 1987, ch. 525, § 13." What operates alongside it is individual licensure under the Board of Medicine, and — under a DIFFERENT board — premises licensure: § 43-11-28(2) caps an “Establishment, original license” at $150.00 and its annual renewal at $100.00: an application to practice medicine goes to the Board of Medicine through its executive director, and every applicant must file a written application on the board’s forms showing it satisfies all of the chapter’s requirements. These claims establish how an individual is licensed; they do not establish any premises or facility registration.
North Dakota answers the compounded-semaglutide question in the definition, and neither limb reaches a clinic buying stock. "Compounding" means the preparation, mixing, assembling, packaging, or labeling of a drug or device: a. As the result of a practitioner's prescription drug order or initiative based on the practitioner, patient, and pharmacist relationship in the course of professional practice; or b. For the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing. Limb (a) needs a prescription order resting on the practitioner-patient-pharmacist relationship; limb (b) is research and is expressly not for sale or dispensing.
N.D. Cent. Code § 43-15-01 (definition of “Compounding” — two limbs, one of them not for sale)
Stock held ahead of the order is permitted, and what may justify it is fixed. Compounding also includes the preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns. The anticipation must rest on prescribing already observed.
N.D. Cent. Code § 43-15-01 (anticipatory stock is allowed, bounded by observed prescribing)
And both acts sit inside the licensed practice. The compounding, dispensing, and labeling of drugs and devices except labeling by a manufacturer, packer, or distributor of nonprescription drugs and commercially packaged legend drugs and devices
N.D. Cent. Code § 43-15-01 (compounding and dispensing are both the practice of pharmacy)
North Dakota caps the cost of entry in statute rather than setting it, which is a different answer and has to be read as one. Fees to be paid by applicants as required under this chapter may not exceed the following amounts: a. Fees: Maximum fee: (1) Establishment, original license $150.00 (2) Establishment, annual renewal $100.00 per year These are ceilings the board may not exceed, not the amounts actually charged — the board sets the real figure beneath them by rule, so an operator should treat $150.00 as the most an establishment license can cost, not the price.
N.D. Cent. Code § 43-11-28(2) (what it costs to open — statutory MAXIMUM fees, not set prices)
The practitioner side is capped separately and far lower. (13) Esthetician, original license $50.00 (14) Esthetician, annual renewal $50.00 per year with the advanced esthetician license capped at the same $50.00, so premises and practitioner together are capped at $200.00 in year one.
N.D. Cent. Code § 43-11-28(2)(a) (the practitioner licenses a studio also pays)
License required. Repealed by S.L. 1987, ch. 525, § 13.
N.D.C.C. § 43-17-16 (Repealed — there is no standing "License required" section)
In order to obtain a license to practice medicine in this state, an application must be made to the board through the executive director .
Every applicant for licensure shall file a written application, on forms provided by the board, showing to the board's satisfaction that the applicant satisfies all of the requirements of this chapter
Advertising rules4 cited rules
Advertising reaches a North Dakota physician through the disciplinary grounds.
Disciplinary landscape6 cited rules
Two boards, two lists. Section 43-17-31(1) opens the Board of Medicine’s grounds — disciplinary action may be imposed upon any of the grounds that follow — and the first is the use of a false, fraudulent or forged statement or document, or a fraudulent, deceitful, dishonest or immoral practice, in connection with any licensing requirement. The Board of Nursing’s powers under 43-12.1-14 are stated as a range rather than a single sanction: it may deny, limit, revoke, encumber or suspend a license, reprimand or place on probation, deny admission to the examination, require evidence of evaluation and treatment, or issue a nondisciplinary letter of concern.
Disciplinary action may be imposed against a physician upon any of the following grounds:
The use of any false, fraudulent, or forged statement or document, or the use of any fraudulent, deceitful, dishonest, or immoral practice, in connection with any of the licensing requirements.
N.D.C.C. § 43-17-31(1)(a) (Fraud or deceit in the licensing process)
The board may deny, limit, revoke, encumber, or suspend any license or registration to practice nursing issued by the board or applied for in accordance with this chapter; reprimand, place on probation, or otherwise discipline a licensee, registrant, or applicant; deny admission to licensure or registration examination; require evidence of evaluation and treatment; or issue a nondisciplinary letter of concern
N.D.C.C. § 43-12.1-14 (What the Board of Nursing may impose)
It is a class B misdemeanor for a person to willfully:
N.D.C.C. § 43-12.1-15 (Unlicensed practice is a class B misdemeanor)
or an unlicensed assistive person as defined by this chapter unless licensed to do so.
N.D.C.C. § 43-12.1-15(4) (Practicing in any nursing role without a license)
Employ a person to practice nursing or perform nursing interventions unless the person is licensed or registered by the board.
N.D.C.C. § 43-12.1-15(6) (The EMPLOYER commits the offense too)
Current as of Sep 8, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.
Who may perform it in North Dakota?
We hold North Dakota’s own written limits for chemical peel, injectable (neuromodulator, dermal filler), microneedling / collagen induction, micropigmentation / permanent makeup, sclerotherapy, body contouring (cryolipolysis, RF, ultrasound), mechanical exfoliation (dermaplaning, microdermabrasion), energy device (laser, IPL, RF, plasma, ultrasound), hair removal (laser / IPL) — read at source and cited. Check a licence against a procedure and see the rule it rests on.
Check scope in North Dakota →North Dakota med spa compliance — FAQ
- Where do North Dakota med spa and injectable regulations come from?
- North Dakota med spas and injectors are governed by a mix of state and federal authorities — the North Dakota legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. MedSpaRadar monitors all of them for North Dakota and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in North Dakota?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in North Dakota. We track those federal changes alongside any North Dakota-specific rules so you see the full picture for your practice.
- How do I keep up with North Dakota regulatory changes?
- MedSpaRadar sends a free weekly Brief on what changed across North Dakota, the FDA, and the Federal Register. Members get the exact "what to do" for their states in one daily email. It's regulatory monitoring, not legal advice.
Get North Dakota changes as they publish
We scan the North Dakota legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
Related
- The Practice Perimeter — the decisions every state makes about a practice, and where each answer lives
- MedSpaRadar vs an AmSpa membership — published prices, what each includes, and when a membership is the better buy
- “Med spa compliance software” means two different things — which half of compliance you are actually shopping for
← All states · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director.